Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · IEX Real-Time Price · USD
4.200
-0.710 (-14.46%)
At close: May 17, 2024, 4:00 PM
4.470
+0.270 (6.43%)
After-hours: May 17, 2024, 7:41 PM EDT
Dermata Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for DRMA.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for DRMA.
Recommendation Trends
Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 |
---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Maintains $240 → $60 | Strong Buy | Maintains | $240 → $60 | +1,328.57% | Mar 23, 2023 |
Brookline Capital | Brookline Capital | Strong Buy Initiates $3,360 | Strong Buy | Initiates | $3,360 | +79,900.00% | Sep 21, 2021 |
Maxim Group | Maxim Group | Strong Buy Initiates $2,160 | Strong Buy | Initiates | $2,160 | +51,328.57% | Sep 14, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.41
from -40.05
EPS Next Year
-0.67
from -1.41
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.45 | -0.69 | -0.59 |
Avg | -1.41 | -0.67 | -0.57 |
Low | -1.35 | -0.65 | -0.55 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.